Rocket Lab (RKLB) saw its shares soar by over 34% in premarket trading following an impressive Q1 earnings report, which revealed a 63.5% year-over-year sales increase to $200.3 million and a record GAAP gross profit margin of 38.2%. The company’s strong performance not only exceeded analyst expectations but also highlighted a robust backlog, with more launch contracts signed in Q1 2026 than all of 2025 combined, including five contracts for its new Neutron rocket.
This surge in revenue and contract acquisitions underscores Rocket Lab’s potential for sustained growth, with the company projecting Q2 sales could reach $240 million, representing a 66% increase. Despite its current valuation of $45 billion and a high price-to-sales ratio of 67, analysts anticipate that Rocket Lab could achieve $867 million in revenue this year, with projections suggesting a tenfold increase by 2035.
For market professionals, Rocket Lab’s strong quarterly performance and ambitious growth outlook may present a compelling investment opportunity, particularly if the company continues to outperform analyst forecasts.
Source: fool.com